P-BCMA-101

· Poseida Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for P-BCMA-101, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101 [Phase 1]